On this page
What is PTSD?
Post-Traumatic Stress Disorder (PTSD) is a chronic and debilitating psychiatric condition that develops within 3 months of direct or indirect exposure to one or more traumatic events.
Traumatic events responsible for the disorder are unusual situations that represent a genuine threat to survival or personal integrity. These may include:
- War and combat exposure
- Serious physical injury
- Rape and sexual assault
- Childhood sexual abuse
- Physical violence and interpersonal violence
- Severe road traffic accidents
- Natural disasters
- Torture
- Genocide
PTSD is not simply a reaction to stress. It represents a profound disruption of the way the brain processes fear, memory, and threat perception, and it can significantly impair an individual’s daily functioning, relationships, and quality of life.
Prevalence and Course
The annual prevalence of PTSD in Europe is approximately 0.5-1%, compared to 3.5% in the United States. Prevalence is notably higher in certain professions with increased likelihood of exposure to traumatic events, including military personnel, firefighters, and emergency medical workers.
Prevalence increases in proportion to:
- The quantity of traumatic events experienced (repeated traumas over time, such as childhood sexual abuse)
- The severity of the trauma
- The intentionality of the trauma (whether the event was deliberately inflicted by another person or group)
The highest rates of PTSD have been documented among survivors of kidnapping, military combat and captivity, and ethnic or political genocide.
PTSD can develop at any age, including in the first year of life. Symptoms generally appear within the first 3 months following the traumatic event, although delayed expression of symptoms by several months is also recognized clinically.
The duration and intensity of symptoms may fluctuate over time. In approximately half of all cases, symptoms resolve within 3 months of onset. However, in other cases, symptoms may persist for years. Recurrence and intensification of symptoms can be triggered by environmental stimuli associated with the original trauma (for example, strong winds in hurricane survivors) or by the physical and cognitive decline and social isolation that may accompany aging.
Causes and Risk Factors
The necessary condition for PTSD is the traumatic event itself, which must have threatened the survival or physical integrity of the individual. However, it is the dynamic interaction between biological and psychosocial factors that shapes the onset, development, and course of symptoms.
These factors are divided into three categories:
Pre-Traumatic Factors (Prior to the Event)
- Female sex: The increased risk in women is not primarily attributable to biological differences between sexes, but rather to the higher statistical probability of women being subjected to rape, physical violence, and interpersonal violence, which remain disturbingly prevalent in contemporary society.
- Emotional difficulties and pre-existing mental disorders: including panic disorder, major depressive disorder, obsessive-compulsive disorder, or prior PTSD.
- Environmental factors: socioeconomic disadvantage, prior trauma exposure, family history of psychiatric disorders, and lack of social support.
- Genetic factors: genes involved in the regulation of serotonin (often referred to as the “happiness neurotransmitter”) and cortisol (the primary “stress hormone”) have been implicated in PTSD susceptibility.
Peri-Traumatic Factors (During the Event)
- Severity of the trauma: real or perceived threat to life, serious injury, violence, being a perpetrator or witness of atrocities, and dissociation occurring during the event.
Post-Traumatic Factors (Following the Event)
- Temperament-related: pessimism and inadequate stress management strategies.
- Environmental: ongoing exposure to reminders of the trauma, subsequent adverse life events, and the absence of adequate social support during the recovery period.
Understanding these risk factors is critical not only for identifying vulnerable individuals but also for designing early intervention strategies that may prevent the full development of PTSD after trauma exposure.
Symptoms and Diagnostic Criteria
The clinical manifestations of PTSD are varied. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), a formal diagnosis requires the presence of specific criteria, outlined below.
Criterion A: Exposure to a Traumatic Event
Exposure to actual or threatened death, serious injury, or sexual violence in one or more of the following ways:
- Direct experience: war, real or threatened physical attack, real or threatened sexual violence, kidnapping, terrorist attack, torture, natural disasters, or serious road traffic accidents.
- Witnessing the event occurring to others: observing threats, serious injury, unnatural death, sexual abuse, violent assault, domestic violence, or road accidents.
- Learning about the event occurring to a close family member or friend. In cases of death, the event must have been violent or accidental (violent personal assault, suicide, serious injury).
- Repeated or extreme exposure to aversive details of traumatic events (for example, first responders collecting human remains). Exposure through media, television, or social networks does not qualify under this criterion.
Criterion B: Intrusion Symptoms (one or more required)
Symptoms must persist for more than one month and cause significant impairment in daily functioning:
- Recurrent, involuntary, and intrusive distressing memories of the traumatic event. In children, these may manifest as repetitive play in which themes of the trauma are expressed.
- Recurrent distressing dreams related to the event. In children, there may be frightening dreams without recognizable content.
- Dissociative reactions (flashbacks) in which the person feels or acts as if the traumatic event is recurring, ranging from brief visual or sensory intrusions with maintained contact with reality to complete loss of awareness of the surrounding environment. These dissociations can last from a few seconds to several hours or even days. In children, trauma re-enactment may occur during play.
- Intense or prolonged psychological distress or marked physiological reactions to internal or external cues that symbolize or resemble an aspect of the traumatic event (for example, windy days after surviving a hurricane, or encountering someone who resembles the perpetrator).
Criterion C: Avoidance (one or both required)
- Avoidance of or efforts to avoid distressing memories, thoughts, or feelings about or closely associated with the traumatic event.
- Avoidance of or efforts to avoid external reminders (people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings.
Criterion D: Negative Alterations in Cognition and Mood (two or more required)
- Inability to remember important aspects of the traumatic event (dissociative amnesia not due to substances or brain injury).
- Persistent exaggerated negative beliefs about oneself, others, or the world (“I am a failure”, “I am bad”, “No one can be trusted”, “The world is completely dangerous”, “I am beyond recovery”).
- Persistent distorted cognitions about the cause or consequences of the traumatic event leading to self-blame or blaming others (“It’s my fault I was raped”).
- Persistent negative emotional states such as fear, horror, guilt, shame, or anger.
- Markedly diminished interest or participation in significant activities.
- Feelings of detachment or estrangement from others.
- Persistent inability to experience positive emotions (happiness, love, satisfaction).
Criterion E: Marked Alterations in Arousal and Reactivity (two or more required)
- Irritable behavior and angry outbursts (with little or no provocation), typically expressed as verbal or physical aggression toward people or objects.
- Reckless or self-destructive behavior, including suicidal behavior.
- Hypervigilance (a state of constant alertness and watchfulness).
- Exaggerated startle response to innocuous stimuli.
- Problems with concentration.
- Sleep disturbances including nightmares or anxiety-related insomnia.
Consequences and Prognosis
PTSD produces significant impairment across multiple domains:
- Physical health: individuals with PTSD have higher rates of somatic complaints, cardiovascular disease, immune dysfunction, and overall increased healthcare utilization.
- Psychological wellbeing: the disorder is frequently associated with comorbid depression, anxiety disorders, and substance use.
- Social functioning: PTSD can profoundly affect interpersonal relationships and social participation.
The consequences for patients can be severe and far-reaching, manifesting as:
- Poor or absent interpersonal relationships, progressing in some cases to complete social isolation.
- Reduced occupational performance and academic achievement.
- Suicidal ideation or suicide attempts, particularly in cases involving childhood abuse.
Patients with PTSD have an approximately 80% increased probability of also meeting criteria for major depressive disorder, bipolar disorder, anxiety disorders, or substance abuse (especially in males), underscoring the importance of thorough comorbidity assessment.
Diagnosis
The goals of PTSD diagnosis are to:
- Identify the trauma (or traumas) that precipitated the disorder.
- Evaluate symptoms and their severity, including frequency, intensity, and functional impact.
- Perform a differential diagnosis, excluding other conditions that share symptoms with PTSD, such as:
- Adjustment disorder
- Acute stress disorder
- Anxiety disorders
- Obsessive-compulsive disorder
- Depressive disorder
- Dissociative disorders
- Identify comorbidities, recognizing associated conditions that require parallel treatment.
- Select the most appropriate treatment strategy based on the clinical picture.
Several validated instruments are used in clinical practice, varying according to the stage of assessment:
- Initial assessment tools: Clinician-Administered PTSD Scale (CAPS), PTSD Symptom Scale-Interview Version (PSS-I), Primary Care PTSD Screen (PC-PTSD).
- Advanced diagnostic tools: Structured Clinical Interview for DSM-5 Disorders (SCID-5), PTSD Checklist for DSM-5 (PCL-5).
Early and accurate diagnosis is fundamental to initiating effective treatment and preventing the long-term complications associated with untreated PTSD.
Treatment
Given the combined psychological and biological nature of PTSD, the most effective therapeutic approach integrates both dimensions. Psychotherapy represents the primary treatment modality, but the early combination of psychological and pharmacological interventions after trauma exposure can significantly reduce symptom severity and, in some cases, prevent the full development of the disorder.
Psychotherapy
Exposure-Based Interventions
These approaches are grounded in the principle that behaviors and emotional responses can be conditioned and modified. They involve gradual and systematic exposure to feared stimuli (such as traumatic memories or triggering situations) in the absence of the anticipated negative consequences (such as physical harm). Through repeated exposure, the fear response associated with the stimulus progressively diminishes through a process of new learning and inhibition of conditioned fear.
Prolonged Exposure (PE) therapy is one of the most extensively researched and validated exposure-based treatments for PTSD, supported by robust clinical evidence.
Cognitive Therapies
Cognitive approaches focus primarily on the dysfunctional thought patterns underlying avoidance behavior. Rather than targeting behavior directly, they intervene at the level of maladaptive beliefs, such as misinterpretations of threat and distorted attributions of blame. Cognitive Processing Therapy (CPT) is a well-validated cognitive approach that addresses the “stuck points” in thinking that maintain PTSD symptoms.
Stress Inoculation Training (SIT)
This model is based on the premise that stress arises from the individual’s perception of an imbalance between environmental demands and personal coping resources, with demands perceived as exceeding resources. The goal of SIT is to increase mastery over anxiety through stress management techniques involving progressively increasing exposure to anxiety-provoking situations, effectively functioning as a psychological “vaccine” against future stressors.
EMDR (Eye Movement Desensitization and Reprocessing)
EMDR is based on the hypothesis that PTSD results from inadequate processing of traumatic memories. During EMDR sessions, the patient is guided to recall distressing memories while simultaneously undergoing bilateral sensory stimulation (typically guided eye movements). Through this process, the individual learns to manage negative emotions associated with the trauma and to restructure the distorted thoughts accompanying them.
EMDR is recognized as an evidence-based treatment for PTSD by the World Health Organization (WHO) and the American Psychological Association (APA), and it has demonstrated efficacy comparable to that of trauma-focused cognitive-behavioral therapies in multiple randomized controlled trials.
Pharmacological Therapy
Pharmacological treatment plays an important complementary role in the management of PTSD, particularly when psychotherapy alone is insufficient or when comorbid conditions require medication management.
Serotonergic antidepressants (selective serotonin reuptake inhibitors, SSRIs, and serotonin-norepinephrine reuptake inhibitors, SNRIs) are the first-line pharmacological treatments for PTSD. By rebalancing the neurotransmitter systems implicated in symptom generation, these antidepressants improve:
- Avoidance behaviors
- Negative emotional states
- Hyperarousal
- Overall quality of life
Sertraline and paroxetine are the only FDA-approved medications specifically indicated for PTSD, though other agents such as venlafaxine and fluoxetine also have supporting evidence. Treatment duration is generally recommended for at least 12 months to prevent relapse.
Other pharmacological agents, such as prazosin (for nightmares and sleep disturbance), may be used as adjunctive treatments in selected patients, though the evidence base for these agents is more limited.
It is important that pharmacological treatment always be conducted under psychiatric supervision, with regular monitoring of efficacy and tolerability, and ideally in conjunction with psychotherapy.
Sources and Bibliography
- Ciaramella A. Manuale di Medicina Psicosomatica. 2015. Aracne Editrice int.le S.r.l., Rome.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.
- Lancaster CL, et al. Posttraumatic Stress Disorder: Overview of Evidence-Based Assessment and Treatment. J Clin Med. 2016;5(11):105.
- World Health Organization. Guidelines for the Management of Conditions Specifically Related to Stress. Geneva: WHO; 2013.
- Foa EB, Keane TM, Friedman MJ, Cohen JA. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. 2nd ed. New York: Guilford Press; 2009.
- National Institute for Health and Care Excellence (NICE). Post-traumatic stress disorder (NICE guideline NG116). London: NICE; 2018.
